November 15, 2024 02:18 PM ESTUpdated November 15, 08:14 PM
Diagnostics
Law

Il­lu­mi­na seeks to dis­miss share­hold­er law­suit, de­nies se­cret $800M stake

Jared Whitlock

Features Editor

Il­lu­mi­na has moved to dis­miss a se­cu­ri­ties law­suit against the com­pa­ny and for­mer board mem­bers over the $8 bil­lion Grail deal, af­ter claim­ing to re­fute …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

Ma­jor PBM re­forms fea­ture in Con­gress' year-end spend­ing bill

What Trump’s FTC picks mean for bio­phar­ma deal­mak­ing and PBMs

Up­dat­ed: Ver­tex’s non-opi­oid pill dis­ap­points in mid-stage chron­ic pain study

A service from the Financial Times